Mlcoch, Tomas http://orcid.org/0000-0002-7716-8819
Decker, Barbora http://orcid.org/0000-0003-3205-0662
Dolezal, Tomas
Article History
Accepted: 28 November 2020
First Online: 11 January 2021
Declarations
:
: Medac Czech Republic partly supported the preparation of the analysis for the purposes of obtaining reimbursement from public health insurance in the Czech Republic. However, the preparation of the publication was not financially supported.
: TM and BD are employees of Value Outcomes. Value Outcomes is a consultancy company working for the pharmaceutical industry in the field of market access, health economics, and outcomes research. TD is the director and owner of Value Outcomes.
: Not applicable.
: Not applicable.
: Not applicable.
: The authors confirm that the data supporting the findings of the analysis are publicly available within the article, its supplementary materials and the articles referenced in the manuscript.
: The cost-effectiveness model is available from the author TM upon request.
: All authors contributed to the analysis conception, its design, and the material preparation and data collection. The analysis was performed by TM, clinical background was provided by BD, and collection of inputs was done by all authors. The manuscript was written by BD and TM, all authors commented on each version of the manuscript. All authors read and approved the final manuscript. TD supervised the process.